CAM
ALXN

ClariVest Asset Management’s Alexion Pharmaceuticals ALXN Stock Holding History

ClariVest Asset Management’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-2,454
Closed -$281K – 844
2020
Q3 		$281K Sell
2,454
-100
-4% -$10.8K 0.01% 424
2020
Q2 		$287K Hold
2,554
– – 0.01% 491
2020
Q1 		$229K Sell
2,554
-200
-7% -$19.6K 0.01% 474
2019
Q4 		$298K Buy
+2,754
New +$295K 0.01% 453
2014
Q4 		– Sell
-10
Closed -$2K – 631
2014
Q3 		$2K Hold
10
– – ﹤0.01% 522
2014
Q2 		$2K Hold
10
– – ﹤0.01% 525
2014
Q1 		$2K Hold
10
– – ﹤0.01% 543
2013
Q4 		$1K Hold
10
– – ﹤0.01% 583
2013
Q3 		$1K Hold
10
– – ﹤0.01% 545
2013
Q2 		$1K Buy
+10
New +$964 ﹤0.01% 522

Other funds holding ALXN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return